A rigorous analysis of the effects of different PDE inhibitors on lipid metabolism and investigation into the mechanism(s) by which these clinically approved drugs act to modulate cancer cell metabolism should be a focus of future studies. This evidence concerns the gene ALDH7A1 and cancer.